Fever-Tree gets a tonic from premium gins

DEMAND FOR posh tonic to accompany the raft of'‹ new '‹premium gin brands saw earnings at Fever-Tree leap 82 per cent last year.

Reporting its first full-year results since listing in 2014,​ ​Fever-Tree​ ​said it was an “exceptional year” for the business.

The company saw full​ ​year pre-tax profits rocket to £16.8​m​, up from £2.5m the year before, while revenues also climbed 71​ ​per cent​ ​to £59.3m.

Hide Ad
Hide Ad

The firm was bolstered by an 84​ ​per cent​ ​rise in UK sales for 2015, helped in part by a strong performance over Christmas.

It has also been boosted by prestigious ​contract wins with the likes of Marks & Spencer and British Airways.

Fever-Tree was named the no.1 best-selling and no.1 trending tonic water in Drinks International’s survey of the world’s top 250 bars.

Charles Rolls, ​e​xecutive ​d​eputy ​c​hairman of Fever-Tree​,​ said:​ ​“Fever-Tree’s on-going success is driven by a global consumer desire and demand to drink premium mixers to complement their premium spirits, and our strong first mover advantage.

Hide Ad
Hide Ad

​“​We are increasingly well positioned to take advantage of the growth in both the ​o​n and ​o​ff-​t​rade in all geographies with the brand’s growing international reputation.

​“​We maintain that the premium segment is still in its infancy and will continue to outperform the other drinks categories as global cross-category premiumisation continues to gain prominence.”

Tim Warrillow, CEO of Fever-Tree​, added​:​ ​“2015 was an exceptional first full year for Fever-Tree as a public company in which we continued to strengthen our reputation as the leading international premium mixer brand. ​In our tenth year of trading we achieved a 71​ per cent​ increase in revenue and ​an 82 per cent​ increase in adjusted EBITDA, underpinned by strong, improving margins.

​“​Growth was strong across all of our four main geographical regions illustrating the global appeal of the brand. We have had an encouraging start to 2016 and look forward to the future with confidence.”

Analyst Nicola Mallard at Investec said: “A strong year for Fever-Tree. There remain ample opportunities for further penetration gains in all geographies and in both on and off trade channels.”

Related topics: